Historical award
Vaxine Pty Ltd
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (14 days old).
Fiscal year 2026: data through (14 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $5,832,656.00
- Potential award value
- $18,005,775.00
- Total obligated to date
- $5,832,656.00
Source date: Nov 9, 2026
Recorded work
TO ADVANCE THE NOVEL H7-ADVAX PANDEMIC VACCINE CANDIDATES THROUGH TO PHASE 1 CLINICAL TRIALS THROUGH DELIVERY TO THE GOVERNMENT OF: PRELIMINARY DATA REGARDING ADJUVANT FOR FORMULATIONS (BASE REQUIREMENT/CLIN 001); MANUFACTURED PRODUCT (RELEASE) FOR S
Award activity
- Obligations in covered fiscal years
- −$535,698.00
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75N93018C00024_7529_-NONE-_-NONE-